Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

250 results about "Brucella" patented technology

Brucella is a genus of Gram-negative bacteria, named after David Bruce (1855–1931). They are small (0.5 to 0.7 by 0.6 to 1.5 µm), nonencapsulated, nonmotile, facultatively intracellular coccobacilli. Brucella spp. are the cause of brucellosis, which is a zoonosis transmitted by ingesting contaminated food (such as unpasteurized milk products), direct contact with an infected animal, or inhalation of aerosols. Transmission from human to human, for example through sexual intercourse or from mother to child, is exceedingly rare, but possible. Minimum infectious exposure is between 10 and 100 organisms.

Sheep single nucleotide polymorphism (SNP) molecular marker and use thereof in detecting resistance to brucellosis in sheep

A sheep single nucleotide polymorphism (SNP) molecular marker and use thereof in detecting resistance to brucellosis in sheep are provided, relating to the technical field of molecular marker-assisted breeding. A sheep SNP molecular marker is provided, where the sheep SNP molecular marker is associated with resistance to brucellosis in sheep, and has a nucleotide sequence shown in SEQ ID NO: 1 in which a T / C polymorphism is located at 101st bp. The sheep SNP molecular marker can accurately detect a resistance level of sheep to the brucellosis, and is used for the selection of brucellosis-resistant sheep as well as molecular marker-assisted breeding of the resistance to brucellosis in sheep. The sheep SNP molecular marker effectively improves a breeding efficiency of sheep with brucellosis resistance.
Owner:INST OF ANIMAL SCI OF CAAS

Efficient carbon sequestration Brucella sourced from oil-containing solid waste residues and application of efficient carbon sequestration Brucella

ActiveCN119410513AExcellent characteristics of reducing pollution and fixing carbonimprove featuresBacteriaContaminated soil reclamationBrucella IgGPetroleum Pollution
The invention discloses efficient carbon sequestration Brucella from an oil-containing solid waste residue source and application of the efficient carbon sequestration Brucella. The Brucella is Brucella sp A54-5 with the preservation number of CCTCC (China Center for Type Culture Collection) NO: M20241650. The Brucella is obtained through ARTP mutagenesis and screening by taking Brucella Brucella sp A54 separated from oil-containing solid waste residues of an oil field as a starting strain, has excellent characteristics of reducing pollution and sequestration carbon and relatively strong stress resistance, and has the advantages of deep recycling (soil transformation) of the oil-containing solid waste residues, improvement of the carbon sequestration capacity of petroleum-contaminated soil and improvement of the oil-containing solid waste residues. The method has a wide application prospect in the fields of petroleum-polluted soil remediation and the like, and has great significance in pollution reduction and convergence increase in petroleum and petrochemical industries under the background of supporting double carbon.
Owner:BEIJING YIXINGYUAN PETROCHEMICAL TECHNOLOGY CO LTD +1

Artificial intelligence-based brucellosis space-time prediction method and system

The invention relates to the technical field of space-time prediction, in particular to a brucellosis space-time prediction method and system based on artificial intelligence, and the method comprises the following steps: obtaining case information, calculating an incidence relation, extracting a path sequence, screening a trend direction, and matching a new case to generate prediction data. According to the method, continuous identification of a propagation path is realized by constructing a propagation incidence relation between cases and introducing a spatial directivity index, a non-trend propagation process is screened out through an angle average value and a variance, spatial consistency of path screening is enhanced, and through joint matching of spatio-temporal characteristics of newly-added cases and an existing propagation trend, the propagation path screening efficiency is improved. The sensitivity of prediction to the trend attribution of a new case is improved, the spatial directivity of a potential disease area is enhanced through reverse projection of a trend path and area positioning drop point frequency analysis, and through linkage processing of multi-level path extraction, trend judgment and area coding, the probability of occurrence of the new case is lowered. And the capturing capability of the prediction data on the propagation and evolution characteristics of the brucellosis is improved.
Owner:INNER MONGOLIA MEDICAL UNIV

Brucella with antibacterial activity and application thereof

The invention discloses a Brucella with antibacterial activity and application of the Brucella. The invention discloses Burkholderia sp.HNIV0701, and the preservation number of the Burkholderia sp.HNIV0701 is GDMCC No: 66007. The Burkholderia sp.HNIV0701 disclosed by the invention has a stable, efficient and broad-spectrum antibacterial property, has an inhibition effect on a plurality of plant pathogenic bacteria such as Botryosphaeria dothidea, Phytophthora nicotianae, Fusarium solani, Alternaria alternata, Thanatepora cucurbitae, Ralstonia solanacearum and the like, and also can be used for inhibiting Staphylococcus aureus and / or Listeria monocytogenes, so that the Burkholderia sp.HNIV0701 can be used for inhibiting a plurality of plant pathogenic bacteria such as the Botryosphaeria dothidea, the Phytophthora nicotianae, the Fusarium solanum, the Alternaria solanacearum and the like. The Brucella HNIV0701 can hydrolyze organic phosphorus and can be used for soil improvement. The Brucella HNIV0701 has nitrogen fixation capability and has the potential of promoting plant growth.
Owner:GUANGDONG INST OF MICROBIOLOGY GUANGDONG DETECTION CENT OF MICROBIOLOGY +1

Primer group, kit and detection method for detecting brucella

The invention discloses a primer group, a kit and a method for detecting brucella, and belongs to the technical field of gene detection. The primer group comprises two pairs of specific RPA (recombinase polymerase amplification) primers: a primer pair B1F1 (SEQ ID No.3) and a primer pair B1R1 (SEQ ID No.6) targeting a B1 sequence, and a primer pair B2F1 (SEQ ID No.8) and a primer pair B2R1 (SEQ ID No.11) targeting a B2 sequence. The invention also provides a kit containing the primer group, and a detection method based on the RPA-CRISPR-Cas12a. The invention also provides a kit containing the primer group and a detection method based on the RPA-CRISPR-Cas12a. According to the application, the high efficiency of RPA amplification is combined with the ultrahigh specificity of CRISPR-Cas12a detection, the defects of long time consumption, low sensitivity and easy generation of false positive in the traditional method are overcome, rapid, sensitive and specific detection of Brucella is realized, and the application has important application value in early screening and monitoring of Brucella.
Owner:JILIN UNIV FIRST HOSPITAL

MRNA-LNPs brucella vaccine, expression vector and preparation method of mRNA-LNPs brucella vaccine

The invention discloses an mRNA-LNPs Brucella vaccine, an expression vector and a preparation method thereof. The mRNA-LNPs Brucella vaccine comprises at least one of mRNA of an outer membrane protein BP26 and mRNA of an outer membrane protein Omp 25. According to the present invention, the antigen sequence is optimized, the prepared mRNA Brucella vaccine can stimulate the body to produce strong immunogenicity, and compared with the Brucella vaccine prepared before the sequence optimization, the antibody titer is significantly improved. A mouse immune experiment research result shows that high-titer IgG, IgG1 and IgG2a can be generated. Th1 type reaction, Th2 type reaction or mixed Th type reaction is successfully induced.
Owner:INNER MONGOLIA AUTONOMOUS REGION INT MONGOLIAN MEDICINE HOSPITAL INNER MONGOLIA AUTONOMOUS REGION MONGOLIAN MEDICINE RES INST

Detection kit for identifying brucella and detection method thereof

The invention belongs to the technical field of animal infectious disease pathogen molecule detection, and particularly relates to a detection kit for identifying brucella and a detection method thereof, the kit comprises any one or more of probes with nucleotide sequences as shown in SEQ ID No.1-SEQ ID No.10, and any one or more of primers with nucleotide sequences as shown in SEQ ID No.11-SEQ ID No.20. The kit can accurately identify the individual positive and the mixed positive of the Brucella vaccine A19 strain, the vaccine S2 strain, the vaccine M5 strain and other strains of the Brucella.
Owner:XUHANG BIOTECHNOLOGY (XIAMEN) CO LTD

PCR (Polymerase Chain Reaction) kit and method for identifying brucella pathogen and application

The invention relates to a PCR (Polymerase Chain Reaction) kit and method for identifying brucella pathogens and application. The PCR kit comprises primer pairs and probes for simultaneously detecting brucella BA0711 vaccine strains, M5-9026 vaccine strains, Rev.1 vaccine strains and wild strains. A primer pair for detecting the brucella BA0711 vaccine strain is shown as SEQ ID NO.1-2, and a probe is shown as SEQ ID NO.3; a primer pair for detecting the M5-9026 vaccine strain is shown as SEQ ID NO.4-5, and a probe is shown as SEQ ID NO.6; a primer pair for detecting the Rev.1 vaccine strain is shown as SEQ ID NO.7-8, and a probe is shown as SEQ ID NO.9; a primer pair for detecting positive brucella is shown as SEQ ID NO.10-11, and a probe is shown as SEQ ID NO.12; the kit has the advantages of high sensitivity and strong specificity, and can simultaneously distinguish a plurality of vaccine strains and wild strains.
Owner:湖南省动物疫病预防控制中心 +1

Brucella immunosuppressive gene BtpB deletion vaccine as well as preparation method and application thereof

The invention provides a Brucella immunosuppressive gene BtpB deletion vaccine as well as a preparation method and application thereof, and belongs to the technical field of vaccine strains. The invention provides a suicide plasmid for knocking out a BtpB gene in a bovine brucella A19 vaccine strain and a gene deletion strain prepared on the basis of the suicide plasmid, and the BtpB gene deletion is performed on the brucella A19 strain so as to achieve the purpose of modifying the A19 vaccine. The A19 delta BtpB deletion strain constructed by the invention can reduce damage to host visceral organs, can induce a mouse to generate a high-titer Brucella specific antibody IgG, can better induce the mouse to generate Th1 type cytokines, and can provide better protective efficacy for the mouse than an A19 vaccine strain, so that the A19 delta BtpB deletion strain can be used as a vaccine for the mouse. The A19 delta BtpB deletion strain is expected to become a novel Brucella gene deletion vaccine candidate, and a theoretical basis and a data support are provided for developing a novel Brucella gene deletion vaccine.
Owner:SHIHEZI UNIVERSITY

A specific nano antibody for detecting Brucella Bp26 and its application

The present invention provides a method for preparing a specific nano antibody for detecting Brucella Bp26. The method uses Bp26 recombinant protein to screen in a Brucella phage display library to obtain nucleotide and amino acid sequences of five Bp26-specific nano antibodies, wherein the five Bp26-specific nano antibodies include nano antibody Nb1, nano antibody Nb2, nano antibody Nb3, nano antibody Nb4, and nano antibody Nb5. The present invention also provides a method for constructing an expression vector of the Bp26-specific nano antibody, and the application of the expression vector constructed by the construction method. The fusion protein expressed by the expression vector can be used to establish a simple and rapid competitive ELISA method to detect Brucella Bp26 antibodies in serum. The nano antibody of the present invention has high affinity, can specifically identify Brucella outer membrane protein Bp26, and effectively block the binding of Brucella positive serum to Bp26.
Owner:NORTHWEST A & F UNIV

Recombinant adenovirus based on 33 protective genes of Brucella

The invention discloses a recombinant adenovirus based on 33 protective genes of Brucella, 33 most important protective antigen genes are screened from 89 whole genes of Brucella through a bioinformatics technology, and are recombined into a human type 5 replication-deficient adenovirus vector through a genetic engineering technology. Therefore, the recombinant adenovirus vaccine based on 33 protective genes of Brucella is obtained. The invention effectively overcomes the defects of virus dispersion, virulence recombination, virulence reversion, virulence residue and the like of attenuated vaccine strains such as conventional brucella vaccine strains, gene deletion vaccine strains and the like, is a safe and effective vaccine, has the effect reaching the brucella vaccine evaluation standard formulated by the world animal hygiene organization OIE, and can be applied to prevention of brucellosis.
Owner:YUNNAN AGRICULTURAL UNIVERSITY

A composite microbial agent and its application in remediation or control of persistent organic polluted sites

The present invention relates to a composite microbial agent and its use in the remediation or management of persistent organic polluted sites. The composite microbial agent comprises a composite microorganism comprising Pseudomonas, Bordetella, Dokshima, and Brucella in a ratio of (0.1-10):(0.1-10):(0.5-1):1. This agent improves the remediation efficiency of persistent organic polluted sites and is particularly suitable for green and efficient remediation of soil and groundwater in sandy soil sites and for pollution source reduction risk management. It also offers advantages such as low cost and ease of operation, thus possessing significant application prospects.
Owner:JIANGSU GAIYA ENVIRONMENTAL SCI & TECH CO LTD

Application of Brucella OMP16 monoclonal antibody in the preparation of products for inhibiting Brucella

The present invention belongs to the field of biomedicine technology, and specifically relates to the use of a Brucella OMP16 monoclonal antibody in the preparation of a product for inhibiting Brucella, wherein the heavy chain variable region amino acid sequence of the Brucella OMP16 monoclonal antibody is shown in SEQ ID NO.1, and the light chain variable region amino acid sequence is shown in SEQ ID NO.2. Through in vivo and in vitro tests, the present invention verifies the potential of the OMP16 monoclonal antibody as a therapeutic antibody in the treatment of brucellosis.
Owner:NORTHWEST A & F UNIV

GntR17 gene deleted M5deltagntR17 strain as well as construction method and application of gntR17 gene deleted M5deltagntR17 strain

The invention provides a gntR17 gene deleted strain M5 delta gntR17 as well as a construction method and application thereof, and belongs to the technical field of biology. The M5 delta gntR17 strain is preserved in the China General Microbiological Culture Collection Center (CGMCC), the preservation date is July 4, 2024, and the preservation number is CGMCC NO.46061. The M5 delta gntR17 strain is preserved in the China General Microbiological Culture Collection Center (CGMCC). It is found that the gntR17 gene is a related gene affecting the virulence of the brucella, the virulence of the brucella can be weakened by deletion of the gntR17 gene, the safety is improved, the survival ability of the brucella in cells and a mouse body can be remarkably reduced after deletion of the gntR17 gene, and the gntR17 gene has potential application value. Compared with the original brucella M5 strain, the M5 delta gntR17 strain constructed after the gntR17 gene is knocked out has the advantages that the virulence is weakened, the safety is high, the immune protection similar to that of an M5-90 delta 26 vaccine is realized, and the strain can be used as a candidate attenuated live vaccine strain for preventing animal brucellosis.
Owner:SHANGHAI VETERINARY RESEARCH INSTITUTE CAAS (CHINESE ANIMAL HEALTH & EPIDEMIOLOGY CENTER SHANGHAI BRANCH)

Bovine brucella antibody immunochromatography detection test strip and preparation method and application thereof

The invention relates to the technical field of biological detection, and particularly discloses a bovine brucella antibody immunochromatography detection test strip as well as a preparation method and application thereof. The bovine brucella antibody immunochromatography detection test strip provided by the invention comprises a PVC (Polyvinyl Chloride) bottom plate, a sample pad, a combination pad, a nitrocellulose membrane and a water absorption pad are arranged on the PVC bottom plate; the combination pad contains a mouse anti-bovine IgG monoclonal antibody marked by quantum dot microspheres; a detection line T and a quality control line C are arranged on the nitrocellulose membrane; the detection line T is coated with a brucella LPS antigen, and the quality control line C is coated with a goat anti-mouse IgG polyclonal antibody. The bovine brucella antibody immunochromatography detection test strip provided by the invention has the advantages of no subjective influence of a detector, simplicity and convenience in operation, high detection sensitivity and specificity and the like.
Owner:BEIJING JINNUO BAITAI BIOTECHNOLOGY CO LTD

Brucella sp. 33, vegetable fresh-keeping agent and application of Brucella sp. 33 and vegetable fresh-keeping agent

The invention relates to the field of microorganisms, and in particular relates to a Brucella intermedia 33, a vegetable preservative and application of the Brucella intermedia 33 and the vegetable preservative. The invention provides a strain of Buttiauxella agrestis 33, and the preservation number of the Buttiauxella agrestis 33 is CGMCC (China General Microbiological Culture Collection Center) No.34251. The invention also provides a preparation method of the Buttiauxella agrestis 33. After broccoli is treated by the strain, the postharvest yellowing of the broccoli can be obviously inhibited. Afterwards, the expression of genes related to chlorophyll metabolism pathways and antioxidant enzymes in the broccoli treated by utilizing the Brucella intermedia 33 is detected through real-time fluorescent quantitative reverse transcription PCR, and the result shows that the Brucella intermedia 33 inhibits yellowing of the broccoli after being picked by activating chlorophyll synthesis and the expression of the genes related to the antioxidant enzymes; and the oxidation resistance of the broccoli is improved.
Owner:BEIJING ACADEMY OF AGRICULTURE & FORESTRY SCIENCES +1

Colletotrichum, plague and brucellosis triple RPA detection kit, primer probe composition and application

The invention discloses a triple RPA (recombinase polymerase amplification) detection kit for anthrax, plague and brucellosis, a primer probe composition and application. The invention discloses a bacillus anthracis, bacillus plague and brucella detection kit based on LFD-RPA, a primer probe composition for detecting the bacillus anthracis, a primer probe composition for detecting the bacillus plague, a primer probe composition for detecting the brucella and a primer probe composition for detecting the brucella. The invention further discloses a bacillus anthracis, bacillus plague and brucella detection kit based on the RPA, a primer probe composition for detecting the bacillus anthracis, a primer probe composition for detecting the bacillus plague and a primer probe composition for detecting the brucella. The detection method provided by the invention can be used for simultaneously detecting the bacillus anthracis, the bacillus plague and the brucella, does not need to depend on professionals, can be used for on-site detection, and has the characteristics of simplicity, convenience, rapidness, sensitivity and specificity.
Owner:ACADEMY OF MILITARY MEDICAL SCIENCES

Silicon-based nano material for targeted therapy of brucellosis as well as preparation method and application of silicon-based nano material

The invention relates to a silicon-based nano material for targeted therapy of brucellosis as well as a preparation method and application of the silicon-based nano material. The invention relates to a preparation method of a silicon-based nano material for targeted therapy of brucellosis. The preparation method comprises the following steps: (1) preparing magnetic mesoporous silica; (2) aminating the magnetic mesoporous silica, and modifying the magnetic mesoporous silica with a responsive material and yeast beta-glucan to obtain modified magnetic mesoporous silica; and (3) carrying out antibiotic loading on the modified magnetic mesoporous silica. According to the silicon-based nano material for targeted therapy of brucellosis as well as the preparation method and the application of the silicon-based nano material, the surface of magnetic macroporous mesoporous silica is modified with yeast beta-glucan capable of targeting M cells and glutathione responsive molecules, and a drug delivery system sensitive to a brucellosis environment is synthesized; the nano-carrier has targeted targeting selectivity for delivering and releasing drugs, the activity, slow release and target cell uptake efficiency of antibiotics are ensured, and the brucellosis treatment is more accurate and efficient.
Owner:SHIHEZI UNIVERSITY